病态肥胖患者下肢关节置换术后肺栓塞或近端深静脉血栓风险是否增加?一项大型数据库研究
该回顾性数据库研究纳入2016年至2020年北爱尔兰8033例初次下肢关节置换术患者,比较BMI≥40 kg/m²与<40 kg/m²者术后90天内肺栓塞或近端深静脉血栓的 odds。结果显示两组肺栓塞和近端深静脉血栓的 odds 均无显著差异,诊断性影像阳性比例亦无显著差异。作者认为不应基于疑似临床重要静脉血栓栓塞风险而将高BMI患者排除在下肢关节置换术之外。
要点
- BMI≥40 kg/m²与<40 kg/m²患者术后90天内肺栓塞 odds 无显著差异(OR 1.0,95%CI 0.4-2.8,p>0.99)。
- 近端深静脉血栓 odds 两组亦无显著差异(OR 2.3,95%CI 0.3-17.0,p=0.72)。
- CT肺动脉造影和超声检查阳性比例在两组间均无显著差异。
核心结论
- 作者认为,不应基于疑似临床重要静脉血栓栓塞风险而将高BMI患者排除在下肢关节置换术之外。
- 作者认为,国家静脉血栓栓塞风险分层工具应仅基于评估临床相关静脉血栓栓塞(近端深静脉血栓、肺栓塞或血栓栓塞死亡)的证据。
研究设计与样本
- 回顾性收集北爱尔兰电子护理记录(Northern Ireland Electronic Care Record)数据库数据,纳入2016年1月至2020年12月期间8033例初次下肢关节置换术关节,其中全髋关节置换4184例、全膝关节置换3494例、单间室膝关节置换355例,所有患者随访90天。
- 排除2184个关节(2183例为多次关节置换患者,1例无BMI记录),最终纳入8033个关节进行分析。
- 以BMI 40 kg/m²为界分组,并按WHO BMI分类评估性别、年龄、美国麻醉医师协会分级、置换关节、静脉血栓栓塞预防、手术医师级别和假体骨水泥状态等混杂变量。
- 使用Wells评分指导检查;疑似肺栓塞行CT肺动脉造影的指征包括胸膜性胸痛、血氧饱和度降低、呼吸困难或咯血;疑似近端深静脉血栓行超声检查的指征包括腿部肿胀、疼痛、皮温升高或红斑;远端深静脉血栓因不采用改良抗凝治疗而记录为阴性扫描。
主要发现
- BMI<40 kg/m²组与BMI≥40 kg/m²组肺栓塞发生率分别为0.8%(58/7506)和0.8%(4/527),OR 1.0(95%CI 0.4-2.8),p>0.99。
- BMI<40 kg/m²组与BMI≥40 kg/m²组近端深静脉血栓发生率分别为0.4%(33/7506)和0.2%(1/527),OR 2.3(95%CI 0.3-17.0),p=0.72。
- 接受诊断性影像检查者中,BMI<40 kg/m²组CT肺动脉造影阳性率为21%(59/276),BMI≥40 kg/m²组为14%(4/29),OR 1.6(95%CI 0.6-4.5),p=0.47。
- 接受诊断性影像检查者中,BMI<40 kg/m²组超声阳性率为4%(34/718),BMI≥40 kg/m²组为2%(1/57),OR 2.7(95%CI 0.4-18.6),p=0.51。
- BMI<40 kg/m²组与BMI≥40 kg/m²组CT肺动脉造影开单比例分别为4%(276/7506)和5%(29/527),OR 0.7(95%CI 0.5-1.0),p=0.07;超声开单比例分别为10%(718/7506)和11%(57/527),OR 0.9(95%CI 0.7-1.2),p=0.49。
关键数值与推荐
- 研究未报告基于BMI的静脉血栓栓塞风险分层阈值或推荐意见。
临床怎么用
- 作者认为,不应基于疑似临床重要静脉血栓栓塞风险而将高BMI患者排除在下肢关节置换术之外。
- 作者认为,国家静脉血栓栓塞风险分层工具应仅基于评估临床相关静脉血栓栓塞(近端深静脉血栓、肺栓塞或血栓栓塞死亡)的证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether increased BMI is associated with an increased risk of venous thromboembolism (VTE) is controversial. Despite this, BMI > 40 kg/m 2 remains a common cutoff for lower limb arthroplasty eligibility. Current United Kingdom national guidelines list obesity as a risk factor for VTE, but these are based on evidence that has largely failed to differentiate between potentially minor (distal deep vein thrombosis [DVT]), and more harmful (pulmonary embolism [PE] and proximal DVT) diagnoses. Determining the association between BMI and the risk of clinically important VTE is needed to improve the utility of national risk stratification tools. QUESTIONS/PURPOSES: (1) In patients undergoing lower limb arthroplasty, is BMI 40 kg/m 2 or higher (morbid obesity) associated with an increased risk of PE or proximal DVT within 90 days of surgery, compared with patients with BMI less than 40 kg/m 2 ? (2) What proportion of investigations ordered for PE and proximal DVT were positive in patients with morbid obesity who underwent lower limb arthroplasty compared with those with BMI less than 40 kg/m 2 ? METHODS: Data were collected retrospectively from the Northern Ireland Electronic Care Record, a national database recording patient demographics, diagnoses, encounters, and clinical correspondence. Between January 2016 and December 2020, 10,217 primary joint arthroplasties were performed. Of those, 21% (2184 joints) were excluded; 2183 were in patients with multiple arthroplasties and one had no recorded BMI. All 8033 remaining joints were eligible for inclusion, 52% of which (4184) were THAs, 44% (3494) were TKAs, and 4% (355) were unicompartmental knee arthroplasties; all patients had 90 days of follow-up. The Wells score was used to guide the investigations. Indications for CT pulmonary angiography for suspected PE included pleuritic chest pain, reduced oxygen saturations, dyspnea, or hemoptysis. Indications for ultrasound scans for suspected proximal DVT included leg swelling, pain, warmth, or erythema. Distal DVTs were recorded as negative scans because we do not treat them with modified anticoagulation. The division of categories was set at BMI 40 kg/m 2 , a common clinical cutoff used in surgical eligibility algorithms. Patients were grouped according to WHO BMI categories to assess for the following confounding variables: sex, age, American Society of Anesthesiologists grade, joint replaced, VTE prophylaxis, grade of operative surgeon, and implant cement status. RESULTS: We found no increase in the odds of PE or proximal DVT in any WHO BMI category. When comparing patients with BMI less than 40 kg/m 2 with those with a BMI of 40 kg/m 2 or higher, there was no difference in the odds of PE (0.8% [58 of 7506] versus 0.8% [four of 527]; OR 1.0 [95% CI 0.4 to 2.8]; p > 0.99) or proximal DVT (0.4% [33 of 7506] versus 0.2% [one of 527]; OR 2.3 [95% CI 0.3 to 17.0]; p = 0.72). Of those who received diagnostic imaging, 21% (59 of 276) of CT pulmonary angiograms and 4% (34 of 718) of ultrasounds were positive for patients with BMI less than 40 kg/m 2 compared with 14% (four of 29; OR 1.6 [95% CI 0.6 to 4.5]; p = 0.47) and 2% (one of 57; OR 2.7 [95% CI 0.4 to 18.6]; p = 0.51) for patients with BMI 40 kg/m 2 or higher. There was no difference in the percentage of CT pulmonary angiograms ordered (4% [276 of 7506] versus 5% [29 of 527]; OR 0.7 [95% CI 0.5 to 1.0]; p = 0.07) or ultrasounds ordered (10% [718 of 7506] versus 11% [57 of 527]; OR 0.9 [95% CI 0.7 to 1.2]; p = 0.49) for BMI less than 40 kg/m 2 and BMI 40 kg/m 2 or higher. CONCLUSION: Increased BMI should not preclude individuals from lower limb arthroplasty based on suspected risk of clinically important VTE. National VTE risk stratification tools should be based on evidence assessing clinically relevant VTE (specifically, proximal DVT, PE, or death of thromboembolism) only. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Thompson R, Cassidy R, Hill J, et al. Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study. Clin Orthop Relat Res. 2023. PMID: 37404124. doi:10.1097/CORR.0000000000002742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。